Geneva, May 18 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124173) titled 'Mechanisms of Sphingolipid Metabolism in Diabetic Kidney disease' on May 8.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: The First Affiliated Hospital of Zhengzhou University
Condition:
Diabetic kidney disease
Intervention:
Normal Control Group:None
Type 2 Diabetes Group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-05-16
Target Sample Size: Normal Control Group:30;Type 2 Diabetes Group:30;Diabetic Nephropathy Group:30;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=321346
Publi...